![](https://ml-eu.globenewswire.com/media/e013b4e1-1aee-46f3-b0e9-3e9bb7d46faa/medium/scirhom-leadership-team-2024.jpg)
SciRhom Secures EUR 63 Million Series A Financing Round to Accelerate iRhom2-targeting Therapies in Autoimmune Diseases
The upsized and oversubscribed Series A financing round will be used to drive the lead development program toward clinical proof-of-concept and to broaden the therapeutic value of the proprietary iRhom2 strategy. Munich, Germany, July 9, 2024 – SciRhom …